Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Cytek BioSciences Inc’s stock clocked out at $5.39, up 4.66% from its previous closing price of $5.15. In other words, the price has increased by $4.66 from its previous closing price. On the day, 0.91 million shares were traded. CTKB stock price reached its highest trading level at $5.56 during the session, while it also had its lowest trading level at $5.03.
Ratios:
To gain a deeper understanding of CTKB’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.50 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.14. For the most recent quarter (mrq), Quick Ratio is recorded 5.47 and its Current Ratio is at 6.21. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on January 31, 2025, Downgraded its rating to Sell and sets its target price to $4.50 from $7 previously.
On December 14, 2023, Stephens started tracking the stock assigning a Overweight rating and target price of $9.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 19 ’24 when Yan Ming sold 20,000 shares for $5.87 per share. The transaction valued at 117,400 led to the insider holds 5,988,502 shares of the business.
Yan Ming sold 1,900 shares of CTKB for $13,304 on Apr 09 ’24. The CHIEF TECHNOLOGY OFFICER now owns 6,008,502 shares after completing the transaction at $7.00 per share. On Mar 18 ’24, another insider, Yan Ming, who serves as the CHIEF TECHNOLOGY OFFICER of the company, sold 20,000 shares for $6.77 each. As a result, the insider received 135,400 and left with 6,030,402 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CTKB now has a Market Capitalization of 694291264 and an Enterprise Value of 431030208. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.45 while its Price-to-Book (P/B) ratio in mrq is 1.81. Its current Enterprise Value per Revenue stands at 2.142 whereas that against EBITDA is -28.438.
Stock Price History:
The Beta on a monthly basis for CTKB is 1.40, which has changed by -0.3513854 over the last 52 weeks, in comparison to a change of 0.21926713 over the same period for the S&P500. Over the past 52 weeks, CTKB has reached a high of $9.33, while it has fallen to a 52-week low of $4.66. The 50-Day Moving Average of the stock is -14.90%, while the 200-Day Moving Average is calculated to be -8.17%.
Shares Statistics:
It appears that CTKB traded 772.83K shares on average per day over the past three months and 696490 shares per day over the past ten days. A total of 129.77M shares are outstanding, with a floating share count of 116.78M. Insiders hold about 9.34% of the company’s shares, while institutions hold 58.08% stake in the company. Shares short for CTKB as of 1736899200 were 3471811 with a Short Ratio of 4.49, compared to 1734048000 on 3693727. Therefore, it implies a Short% of Shares Outstanding of 3471811 and a Short% of Float of 3.47.
